UHPLC Quantitation Method and In vitro Studies of Two New Phthalimide Derivatives Planned to Treat Sickle Cell Disease

E-ISSN： 1875-676x|13|4|361-366

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.13, Iss.4, 2017-06, pp. : 361-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

UHPLC Quantitation Method for New Thiazolidinedione LPSF/GQ-02 and In Vitro/In Vivo Kinetic Studies

Drug Metabolism Letters, Vol. 10, Iss. 3, 2016-09 ,pp. : 206-212

Bentham Science Publishers

Access to resources Recommend Favorite

The genomics of new drugs in sickle cell disease

By Makis Alexandros C Hatzimichael Eleftheria C Stebbing Justin

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 909-917

Future Medicine

Access to resources Recommend Favorite

Sickle cell disease

By Yardumian Anne Crawley Charles

Clinical Medicine, Vol. 1, Iss. 6, 2001-11 ,pp. : 441-446

Royal College Of Physicians

Access to resources Recommend Favorite

Sickle Cell Disease in Children

By > Miller Jeffery L.

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 895-906

Adis International

Access to resources Recommend Favorite

Developing treatment for sickle cell disease

By Brugnara Carlo Steinberg Martin H

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 5, 2002-05 ,pp. : 645-659

Informa Healthcare

Access to resources Recommend Favorite